When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XERS - Xeris Pharma launches Gvoke HypoPen for hypoglycemia in U.S.
Xeris Pharmaceuticals Inc.
Xeris Pharmaceuticals (NASDAQ:XERS) announces that Gvoke HypoPen (glucagon injection) is now available by prescription in U.S. for the treatment of severe hypoglycemia in adults and children with diabetes ages 2 years and above.
More news on: Xeris Pharmaceuticals, Inc., Healthcare stocks news,